Ovastatin

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameOvastatin

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiotherapies Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiotherapies Inc

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

ATC CodeN/A